Animalcare Grp Regulatory News (ANCR)

Animalcare Group plc

("Animalcare")

AGM Statement

Animalcare Group plc (AIM: ANCR), a leading supplier of veterinary medicines, will hold its Annual General Meeting today at The Bridge Hotel, Walshford, Wetherby, North Yorkshire, LS22 5HS at 11.30am.

Ahead of the formal proceedings Animalcare will provide the following update to shareholders:

Trading in the first four months continues its early progress and remains comfortably ahead of prior year, in line with the market and the Board's expectations.

We continue on track to launch four new products during the year ending 30 June 2013. The first of these Vitofyllin, a tablet prescribed for problems associated with canine ageing, was launched in September and is progressing well with repeat orders being received. In addition, we announced on 4 October the granting of a Marketing Authorisation for Marbocare, an injectable presentation of the large animal antibiotic marbofloxacin. Industrial production of Marbocare is now taking place.

The Board was pleased with the underlying cash flow of the business in 2011-12 and that trend has continued in the first quarter of 2012-13. We announced in October that we are recommending a final dividend of 3.0 pence per share giving a total dividend of 4.5 pence per share for the year, up 12.5% compared to 2011. Subject to shareholder approval later in the meeting, we propose to pay this dividend to shareholders on 16 November 2012.

For further information: